All In Biotech

Drug Trial Radar · NCT02614196

Evaluation of Efficay & Safety of Galcanezumab in the Prevention of Episodic Migraine- the EVOLVE-2 Study

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Migraine - the EVOLVE-2 Study

Last checked: Nov 20, 2026Latest source record: Jun 17, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 986 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

986

Actual

Start

Dec 4, 2015

Primary completion

Mar 29, 2017

Study completion Oct 5, 2018

Sponsor

Lead sponsor
Eli Lilly and CompanyEli Lilly (LLY)
Sponsor type
Industry
First posted
Nov 25, 2015

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main purpose of this study is to evaluate the efficacy and safety of the study drug known as galcanezumab in participants with episodic migraine.

Conditions

  • Migraine

Interventions

  • GalcanezumabDrug

    Administered SC

  • PlaceboDrug

    Administered SC

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Overall Mean Change From Baseline in the Number of Monthly Migraine Headache DaysTime frame: Baseline, Month 1 through Month 6

Locations

113 sites in 12 countries. Site status is shown where the registry gives one.

  • 21st Century Neurology

    Phoenix, Arizona

  • Arizona Research Center

    Phoenix, Arizona

  • Axiom Research

    Apple Valley, California

  • Cedars Sinai Medical Center

    Los Angeles, California

  • Catalina Research Institute, LLC

    Montclair, California

  • Pacific Research Partners, LLC

    Oakland, California

  • Medical Center for Clinical Research

    San Diego, California

  • Optimus Medical Group

    San Francisco, California

  • Schuster Medical Research Institute

    Sherman Oaks, California

  • IMMUNOe International Research Centers

    Centennial, Colorado

  • Clinical Research of South Florida

    Coral Gables, Florida

  • Sunrise Clinical Research

    Hollywood, Florida

  • Westside Center for Clinical Research

    Jacksonville, Florida

  • Clinical Neuroscience Solutions Inc

    Jacksonville, Florida

  • Sensible Healthcare

    Ocoee, Florida

  • Meridien Research

    Tampa, Florida

  • Atlanta Center of Medical Research

    Atlanta, Georgia

  • Christie Clinic, LLC

    Champaign, Illinois

  • Diamond Headache Clinic

    Chicago, Illinois

  • Josephson Wallack Munshower Neurology

    Indianapolis, Indiana

  • Heartland Research Associates

    Wichita, Kansas

  • Novex Clinical Research

    New Bedford, Massachusetts

  • QUEST Research Institute

    Farmington Hills, Michigan

  • Healthcare Research Network - Hazelwood

    Hazelwood, Missouri

  • Nevada Headache Institute

    Las Vegas, Nevada

  • Bio Behavioral Health

    Toms River, New Jersey

  • Albuquerque Clinical Trials

    Albuquerque, New Mexico

  • Regional Clinical Research

    Binghamton, New York

  • SPRI Clinical Trials, LLC.

    Brooklyn, New York

  • High Point Clinical Trials Center

    High Point, North Carolina

  • Neurology & Neuroscience Associates, Inc.

    Akron, Ohio

  • Univ of Cincinnati College of Medicine

    Cincinnati, Ohio

  • Urgent Care Specialists, LLC

    Columbus, Ohio

  • Urgent Care Specialists, LLC

    Dayton, Ohio

  • IPS Research Company

    Oklahoma City, Oklahoma

  • Oregon Neurology Associates

    Springfield, Oregon

  • Clinical Research of Philadelphia

    Philadelphia, Pennsylvania

  • Mountain View Clinical Research, Inc

    Greer, South Carolina

  • Coastal Carolina Research Center, Inc.

    Mt. Pleasant, South Carolina

  • FutureSearch Trials

    Dallas, Texas

Showing 40 of 113 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.